2018 American Transplant Congress
Willingness to Accept HIV-Positive and Increased Infectious Risk Donor Organs among HIV-Positive Transplant Candidates
Implementation of HIV+ to HIV+ organ transplantation under the HOPE Act could shorten waitlist times for HIV+ transplant candidates. However, realizing these potential benefits depends…2017 American Transplant Congress
Impact of Ritonavir on Graft Function in Human Immunodeficiency Virus Infected Kidney Transplant Recipients.
Emory University Hospital, Atlanta, GA
Purpose: The purpose of this study was to determine the difference in 6 and 12 month graft function between patients with human immunodeficiency virus (HIV)…2017 American Transplant Congress
HOPE Act – The First Year.
United Network for Organ Sharing, Richmond, VA
Background: The HIV Organ Policy Equity (HOPE) Act, enacted on 11/21/13, allows for research on transplants of kidneys (KI) or livers (LI) from HIV+ donors…2017 American Transplant Congress
Current Status of HIV-to-HIV Transplants in the United States.
1JHU, Baltimore, MD; 2Mount Sinai, New York, NY; 3NIH, Bethesda, MD; 4NYU, New York, NY
The HIV Organ Policy Equity (HOPE) Act allows transplantation using organs from HIV-infected (HIV+) donors for HIV+ individuals in the United States under research protocols.…2017 American Transplant Congress
Using Donors with False Positive HIV Tests – An Unexpected Benefit of the HOPE Act.
Deceased donors are screened for HIV infection using anti-HIV antibody (Ab) and nucleic acid testing (NAT). Historically, organs were discarded in cases of a suspected…2017 American Transplant Congress
Sexual Acquisition of HIV-Infection After Kidney Transplantation: Late Presentation and Potentially Fatal Complications.
Transplant Division, Hospital do Rim-UNIFESP, Sao Paulo, Brazil
Introduction: Transplantation in patients previously infected with HIV is already well established, and cases of donor infection transmission have already been reported. However late acquisition…2017 American Transplant Congress
HIV and Cognitive Impairment in Kidney Transplant Candidates.
Both HIV-infection and end stage renal disease (ESRD) are independently associated with neurocognitive decline. However, the combined impact of these diseases remains unclear, particularly among…2017 American Transplant Congress
Low Incidence of Acute Rejection within the Six Months After Transplantation in HIV Recipients Treated with Raltegravir, the ANRS 153 Treve Trial.
Renal transplantation is safe and effective in HIV patients with end stage renal disease (ESRD). High rates of acute rejection (AR) have been reported because…2017 American Transplant Congress
Antiretroviral Therapy Modification of HIV+ Patients Listed for Kidney Transplantation.
Introduction:HIV+ individuals can receive kidney transplant (KT) safely and effectively but face additional challenges from potential drug interactions between antiretroviral therapy (ART) and immunosuppression(IS). Little…2017 American Transplant Congress
Nonmelanoma Skin Cancer Rates Are Not Affected by Chronic HIV(+) or HCV(+) Infection in Organ Transplant Recipients.
Dermatology, Drexel, Philadelphia
Purpose: HIV and HCV are two immune dysregulatory processes that may exacerbate the risk of nonmelanoma skin cancer (NMSC) in organ transplant recipients (OTR), a…
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 12
- Next Page »